Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria

Diabetologia

Volumn 39, Issue 5, 1996, Pages 587-593

  Boner, G ^b   Van Dyk, D J ^b   Tan, M H ^c   Tan, J ^c   Ekstrand, A ^d   Koivisto, V A ^d   Groop, L C ^d   Groop, P H ^d   Lucas, A ^e   Romero, R ^e   Salinas, I ^e   Sanmarti, A ^e   Escobar, F ^f   Escobar Jimenez, F ^f   Campos Pastor, M M ^f   Mugoz, M ^f   Gomez, M ^f   Mangili, R ^g   Pozza, G ^g   Spotti, D ^g   Hansen, K Wurgler ^h   Christiansen, J Sandahl ^h   Klein, F ^h   Mogensen, C E ^h   Van Doorn, L G ⁱ   Spooren, P F M J ^j   Cruickshank, J K ^k   Jervell, J ^l   Paus, P N ^m   Barnes, D J ⁿ   Collins, A ⁿ   Viberti, G C ^a,n   Williams, G ⁿ   Nelstrop, G A ^o   Amorosa, L ^p   Anolik, J R ^q   Aronoff, S L ^r   Eubank, B ^r   Bailie, M ^s   Pelletier, L ^s   Blevins, T ^t   Charles, M A ^u   Perry, M ^u   Clarke, D ^v   Tomkey, D ^v   Einhorn, D ^w   Humphries, D ^w   Garber, A J ^x   Haag, B ^y   Williams, E ^y   Hoy, W ^z   Watkins, M ^z   Kahkonen, D ^aa   Kruger, D ^aa   Kilo, C ^ab   Laffel, L ^ac   Golden, E ^ac   Lodewick, P ^ad   Lovinsky, ^ad   Mason, J ^ae   Johnson, S ^ae   McGill, J ^af   Schmidt, L ^af   Orlander, P ^ag   Sorenson, K ^ag   Raskin, P ^ah   Hellenbrand, D ^ah   Rosenblatt, S ^ai   Schwartz, S ^aj   Aufieri, J ^aj   Sheehan, J P ^ak   Ulchaker, M ^ak   Skyler, J S ^al   Agramonte, R ^al   Starr, J ^am   Gagliastre, D ^am   Taylor, T ^an   Dawn, K ^an   Ward, W K ^ao   Rigdon, M ^ao   more..

^a ST THOMAS HOSPITAL   (United Kingdom)

^b RABIN MEDICAL CENTER   (Israel)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ Maria Hospital TIlburg   (Netherlands)

^j MEDISCH SPECTRUM TWENTE   (Netherlands)

^k NORTHWICK PARK HOSPITAL   (United Kingdom)

^l OSLO UNIVERSITY HOSPITAL   (Norway)

^m Sentralsykehuset i Akershus   (Norway)

ⁿ GUY S HOSPITAL   (United Kingdom)

^o WATFORD GENERAL HOSPITAL   (United Kingdom)

^p RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^q Larchmont Medical Center   (United States)

^r Endocrine Associates of Dallas   (United States)

^s UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^t Austin Diagnostic Center   (United States)

^u Western Diabetes Association   (United States)

^v Diabetes Health Center   (United States)

^w Sharp Hlth Care Diabet Res Center   (United States)

^x HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^y BAYSTATE MEDICAL CENTER   (United States)

^z LOVELACE CLINIC FOUNDATION   (United States)

^aa HENRY FORD HOSPITAL   (United States)

^ab Kilo Diabet and Vasc Res Found   (United States)

^ac JOSLIN DIABETES CENTER   (United States)

^ad Diabetes Care Center   (United States)

^ae Diabetes Care Center   (United States)

^af WASHINGTON UNIVERSITY   (United States)

^ag UNIVERSITY OF TEXAS   (United States)

^ah UNIVERSITY OF TEXAS   (United States)

^ai Newport Clinic Research Center   (United States)

^aj Diabetes and Glandular Disease Clinic   (United States)

^ak N Coast Inst Diabet/Endocrinol   (United States)

^al Jackson Medical Towers   (United States)

^am Worcester Diabet Metab Assoc I   (United States)

^an GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^ao Portland Diabetes Center   (United States)

more..

Author keywords

angiotensin converting enzyme inhibition; diabetic nephropathy; insulin dependent diabetes mellitus; microalbuminuria

Indexed keywords

CAPTOPRIL; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0342636985     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00403306     Document Type: Article

References (45)

1. Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285: 685-689
2. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 294: 1443-1447
3. Parving HH, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin-dependent diabetics with nephropathy. BMJ 297: 1086-1091
4. Parving HH, Hommel E, Nielsen MD, Giese J (1989) Effect of captopril on blood pressure and kidney function in normotensive insulin-dependent diabetics with nephropathy. BMJ 299: 533-536
5. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930
6. Anderson S, Rennke HG, Garcia DL, Brenner BM (1989) Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36: 526-536
7. Bjorck S, Mulec H, Johnsen SA, Nordén G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339-343
8. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462
9. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430-1432
10. Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR (1982) Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100: 550-555
11. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89-93
12. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26: 406-410
13. Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC (1992) Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus. Kidney Int 41: 836-839
14. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P (1988) Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 297: 1092-1095
15. Melbourne Diabetic Nephropathy Study Group (1991) Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 302: 210-216
16. Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M (1993) Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin-dependent diabetes. BMJ 306: 175-182
17. Mathiesen ER, Hommel E, Giese J, Parving HH (1991) Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 303: 81-87
18. Viberti GC, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group (1994) Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 271: 275-279
19. Laffel L, Gans DJ, McGill JB, on behalf of the Captopril Nephropathy Study Group (1993) Captopril decreases the rate of progression of renal disease in normotensive, insulin-dependent diabetes mellitus (IDDM) patients with microalbuminuria. J Am Soc Nephrol 4: 304 (Abstract)
20. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE (1993) Is screening and intervention for microalbuminuria worthwhile in patients with insulin-dependent diabetes? BMJ 306: 1722-1725
21. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PRN (1987) Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyzer. J Clin Pathol 40: 465-468
22. Stein EA (1986) Lipids, lipoproteins and apolipoproteins. In: Tietz NW (ed) Textbook of clinical chemistry. WB Saunders, Philadelphia, pp 829-900
23. SAS Institute Inc (1991) SAS Technical Report p 217 "SAS/ STAT Software: the PHREG Procedure, Version 6", SAS Institute Inc, Cary, NC
24. SAS Institute Inc (1990) SAS/STAT user's guide, Version 6, 4th edn, SAS Institute, Cary, NC
25. SAS Institute Inc (1992) The MIXED Procedure. In: SAS Technical Report p 229, "SAS/STAT Software: Changes and Enchancements, Release 6.07." SAS Institute Inc, Cary, NC, pp 287-366
26. SAS Institute Inc (1992) The MIXED Procedure. In: SAS Technical Report p 229, "SAS/STAT Software: Changes and Enchancements, Release 6.07." SAS Institute Inc, Cary, NC, pp 287-366
27. Wiedmann P, Boehlen LM, de Courten M (1993) Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 8: 582-584
28. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF (1993) Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Int Med 118: 129-138
29. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M (1993) Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Int Med 118: 577-581
30. Rossing P, Hommel E, Smidt UM, Parving HH (1994) Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int 45:S145-S149
31. Apperloo AJ, De Zeeuw D, De Jong PE (1994) Short-term anti-proteinuric response to anti-hypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int 45:S174-S178
32. Williams JD, Coles GA (1994) Proteinuria - a direct cause of renal morbidity. Kidney Int 45: 443-450
33. Microalbuminuria Collaborative Study Group, UK (1993) Risk factors for the development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ 306: 1235-1239
34. Krolewski AS, Warram JH, Christlieb AR (1994) Hypercholesterolemia - a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 45:S125-S131
35. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T (1991) Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34: 164-170
36. The Diabetes Control and Complications Trial Research Group (1993) The effects of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes. N Engl J Med 329: 977-986
37. Poulsen PL, Hansen KW, Mogensen CE (1994) Ambulatory blood pressure monitoring in the transition from normo- to microalbuminuria. Diabetes 43: 1248-1253
38. Anderson S, Meyer T, Rennke HG, Brenner BM (1985) Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619
39. Raij L, Keane WF (1985) Glomerular mesangium: its function and relationship to angiotensin II. Am J Med 79[Suppl C]: 24-30
40. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I (1989) Effects of antihypertensive drugs on glomerular morphology. Kidney Int 36: 626-635
41. Raij L, Luscher TF, Vanhoutte PM (1988) High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension 12: 562-567
42. The Microalbuminuria Collaborative Study Group, UK (1995) Intensive therapy and progression to clinical albuminuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. BMJ 311: 973-977
43. Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 42: 1703-1720
44. Siegel JE, Krolewski AS, Warram JH, Weinstein WC (1992) Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol 3: 3111-3119
45. Robdy R, Firth L, Lewis E (1994) An economic analysis of captopril in the treatment of diabetic nephropathy. J Am Soc Nephrol 5: 382 (Abstract)